Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Cibus, Inc. (CBUS)

$1.70 -4.49% NASDAQ: CBUS · 15-min delayed
  • SAN DIEGO, California
  • Public · NASDAQ: CBUS
  • 118 employees
$98.5MMarket cap
$3.6MRevenue · FY2025
-$127.1MNet income
118Employees
CBUSNASDAQ
2017IPO

About Cibus, Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$3.6M
Net income
-$127.1M
Total assets
$305.0M
Market cap
$98.5M
Operating margin
-6062.8%
Net margin
-6633.3%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2024

Financial statements

Income statement

Revenue
$4.3M
Operating expenses
$262.7M
Operating income
-$258.4M
Income tax
$29.0K
Net income
-$282.7M
EPS (basic)
$-10.83
EPS (diluted)
$-10.83

Balance sheet

Total assets
$350.1M
Current assets
$16.9M
Total liabilities
$252.2M
Current liabilities
$19.9M
Shareholders’ equity
$92.2M

Cash flow

Operating cash flow
-$58.0M
Investing cash flow
-$808.0K
Financing cash flow
$40.6M
Net cash flow
-$18.3M

Statements via Polygon.io (SEC filings)

NASDAQ: CBUS
$1.70 -4.49%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.16 $4.05

52-week range

Market cap
$98.5M
EPS (diluted)
$-10.83
Shares outstanding
57.9M
Open
Day range
Prev close
Volume
IPO date
Jul 20, 2017

Cibus, Inc. (CBUS) Stock Price

  • Reported a net loss of $127.1M in FY2025.
  • Revenue grew 135% from FY2023 to FY2024.
  • Trading 58% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Cibus, Inc..

Write a review
Newsroom

News about Cibus, Inc.

News & sentiment via Polygon.io

FAQ

Cibus, Inc.: frequently asked questions

Is Cibus, Inc. an American company?

Cibus, Inc. is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Cibus, Inc. headquartered?

Cibus, Inc. is headquartered in San Diego, California, United States.

Is Cibus, Inc. publicly traded?

Yes — Cibus, Inc. is a publicly traded company. Its stock trades under the ticker symbol CBUS on the NASDAQ.

What does Cibus, Inc. do?

Cibus, Inc. is an American Industrial Supplies company in the Manufacturing & Industrial sector.

Explore

Similar companies

Browse all →